Rapamycin-induced proteinuria following allogeneic hematopoietic stem cell transplantation.

about

Rapamycin-induced proteinuria following allogeneic hematopoietic stem cell transplantation.

Item

http://www.wikidata.org/entity/Q46158153

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Rapamycin-induced proteinuria ...... tic stem cell transplantation.

@en

Rapamycin-induced proteinuria ...... tic stem cell transplantation.

@nl

type

Item

label

Rapamycin-induced proteinuria ...... tic stem cell transplantation.

@en

Rapamycin-induced proteinuria ...... tic stem cell transplantation.

@nl

prefLabel

Rapamycin-induced proteinuria ...... tic stem cell transplantation.

@en

Rapamycin-induced proteinuria ...... tic stem cell transplantation.

@nl

P1476

Rapamycin-induced proteinuria ...... tic stem cell transplantation.

@en

P2093

A R Rosenkranz

http://www.w3.org/2001/XMLSchema#string

D Nachbaur

http://www.w3.org/2001/XMLSchema#string

E Wurz

http://www.w3.org/2001/XMLSchema#string

J Clausen

http://www.w3.org/2001/XMLSchema#string

K Hochegger

http://www.w3.org/2001/XMLSchema#string

P2860

Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.

Use of sirolimus in solid organ transplantation.

Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?

Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.

Mechanisms and management of proteinuria in kidney transplant patients.

Differential effects of rapamycin in anti-GBM glomerulonephritis.

Development of proteinuria after switch to sirolimus-based immunosuppression in long-term cardiac transplant patients.

Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy.

The TSC-mTOR signaling pathway regulates the innate inflammatory response.

Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.

P2888

bmt.2008.433

P304

63-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2008.433

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23798891

http://www.w3.org/2001/XMLSchema#string

P6179

1048183662

http://www.w3.org/2001/XMLSchema#string

P698

19151795

http://www.w3.org/2001/XMLSchema#string